MAY 19, 2020. PTC announced delays in its gene therapy program for Friedreich’s ataxia and in the opening of a manufacturing facility in New Jersey, which is now expected to begin producing clinical material early next year.
PTC announced delays in its gene therapy program for Friedreich’s ataxia